Clinical Benefits

Detection of Breast Cancer

CMR Naviscan’s Solo II, High Resolution Breast PET Scanner is an application of PET technology that isolates and images tissue from localized body areas, producing tomographic images of lesions with resolution down to 1.6 mm. This technology produces valuable clinical data on diseased tissue across the continuum of care.  From initial staging to on-going post-surgical disease management, the Naviscan Solo II Scanner provides a metabolic perspective enabling physicians to provide optimal patient care and outcomes.

Clinical studies demonstrate that Breast PET has reliability in the identification of breast cancer of over 90%, resulting in the highest sensitivity and specificity in characterizing the extent and location(s) of breast cancer in newly diagnosed patients.  PET technology provides a much more accurate picture of abnormal tissue. As well, it better differentiates between benign and cancerous lesions, reducing false positives and aids in preventing unnecessary biopsies or surgeries.

 

Monitoring Treatment Response

Breast PET demonstrates how the cancer responds to neo-adjuvant chemotherapy, with goal of shrinking the tumor(s) before surgery and improved patient outcomes.  Breast PET enables breast surgeons and imaging centers the ability to monitor virtually any patient for pre-operative treatments – often after just one cycle of chemotherapy. 

 

Monitoring for Breast Cancer Recurrence

Breast PET better differentiates between scar tissue (from surgery) and tumor, to better monitor for recurrence.  With 90% reliability (both specificity and sensitivity), Breast PET can help identify the recurrence of cancer earlier and at a smaller size.

 

Suitable for All Patients

Breast PET is suitable for virtually all patients, making it an excellent imaging tool for women who are claustrophobic or otherwise unable to tolerate an MRI, such as those with pacemakers or other implanted devices.  Also, Breast PET is not limited by dense breast and can be performed during menstrual cycle.  Because of the gentle immobilization of the breast during the procedures – requires 60% less compression than comparable scanners – Breast PET prevents issues with body motion that skew results and provides a better patient experience. 

 

Breast Surgeons

Breast PET is utilized to characterize the complexity of cancer and guide treatment and/or surgical planning in newly diagnosed breast cancer patients.

Breast PET provides surgeons:

  • The most accurate results
  • Earliest detection of disease and incidental cancers, such as multifocal or contra lateral disease
  • Actionable information, beyond the mammogram and ultrasound, to make more informed decisions regarding treatment plans and/or surgical plans; e.g. whether to proceed with a mastectomy or determine if the patient can be a candidate for a lumpectomy

 

Oncologists

With a higher resolution than whole-body PET systems, Breast PET is a proven method in assessing treatment responses earlier and knowing whether a tumor responds to neoadjuvant chemotherapy.  In cases where a patient has a locally advanced cancer, instead of proceeding with a mastectomy for example, oncologists may opt for pre-operative chemotherapy with the goal of shrinking the tumor prior to surgery.  Following the pre-operative chemo, a Breast PET scan is repeated to evaluate how the cancer has responded to the treatment and how much of the cancer remains. Using the Breast PET modality should ultimately reduce patient morbidity, speed up treatment, and save healthcare dollars.

 

Breast PET provides Oncologists:

  • Visual of how the cancer responds to neo-adjuvant chemotherapy, with goal of shrinking the tumor(s) before surgery and improved patient outcomes
  • Ability to change targeted therapy earlier than with other modalities, where typically an oncologist may have to wait through a second cycle of chemotherapy before changes manifest

Have a question or need more information? Have a CMR Naviscan representative contact you.